Pharmaceutical

Current location:Home > Pharmaceutical

STAUROSPORINE

  • CAS No.: 62996-74-1
  • Purity: 99%
Contact us

Buy Good Quality STAUROSPORINE 62996-74-1 with a minimum purity of 99%

  • Molecular Formula: C28H26N4O3
  • Molecular Weight: 466.539
  • Appearance/Colour: off-white powder 
  • Vapor Pressure: 3.25E-18mmHg at 25°C 
  • Melting Point: 270 °C 
  • Boiling Point: 677.523 °C at 760 mmHg 
  • PKA: 14.25±0.70(Predicted) 
  • Flash Point: 363.553 °C 
  • PSA: 69.45000 
  • Density: 1.562 g/cm3 
  • LogP: 5.07370 

STAUROSPORINE(Cas 62996-74-1) Usage

Biological Activity

Broad spectrum protein kinase inhibitor. Enzymes inhibited include protein kinase C (IC 50 = 3 nM), protein kinase A (IC 50 = 7 nM), p 60v-src tyrosine protein kinase (IC 50 = 6 nM) and CaM kinase II (IC 50 = 20 nM). Also available as part of the Mixed Kinase Inhibitor Tocriset? .

General Description

A potent, cell-permeable, reversible, ATP-competitive and broad spectrum inhibitor of protein kinases. Inhibits CaM kinase (IC50 = 20 nM), myosin light chain kinase (IC50 = 1.3 nM), protein kinase A (IC50 = 7 nM), protein kinase C (IC50 = 0.7 nM), and protein kinase G (IC50 = 8.5 nM). Also inhibits platelet aggregation induced by collagen or ADP but has no effect on thrombin-induced platelet aggregation. Induces apoptosis in human malignant glioma cell lines. Arrests normal cells at the G1 checkpoint.

InChI:InChI=1/C28H26N4O3/c1-28-26(34-3)17(29-2)12-20(35-28)31-18-10-6-4-8-14(18)22-23-16(13-30-27(23)33)21-15-9-5-7-11-19(15)32(28)25(21)24(22)31/h4-11,17,20,26,29H,12-13H2,1-3H3,(H,30,33)/p+1/t17-,20-,26-,28+/m1/s1

62996-74-1 Relevant articles

PROCESS FOR THE PURIFICATION OF INDOLE CARBAZOLE ALKALOIDS

-

Page/Page column 16, (2021/09/11)

Disclosed is a process for the purificat...

COMPOUNDS FOR IMMUNOPOTENTIATION

-

Page/Page column 140, (2010/02/15)

Methods of stimulating an immune respons...

Design and implementation of an efficient synthetic approach to pyranosylated indolocarbazoles: Total synthesis of (+)-RK286c, (+)-MLR-52, (+)-staurosporine, and (-)-TAN-1030a

Wood, John L.,Stoltz, Brian M.,Goodman, Steven N.,Onwueme, Kenolisa

, p. 9652 - 9661 (2007/10/03)

A total synthesis of the natural product...

Total synthesis of (+)-RK-286c, (+)-MLR-52, (+)-staurosporine, and (+)-K252a

Wood, John L.,Stoltz, Brian M.,Goodman, Steven N.

, p. 10656 - 10657 (2007/10/03)

-

62996-74-1 Process route

C<sub>37</sub>H<sub>34</sub>N<sub>4</sub>O<sub>6</sub>
195617-12-0

C37 H34 N4 O6

staurosporine
62996-74-1

staurosporine

Conditions
Conditions Yield
Multi-step reaction with 3 steps
1: 79 mg / H2 / PtO2 / aq. acetic acid
2: 2.) BH3 *DMS / 1) THF; 2) THF, toluene, reflux, 2 h
3: 70 percent / TFA, anisole / 48 h
With dimethylsulfide borane complex; hydrogen; methoxybenzene; trifluoroacetic acid; platinum(IV) oxide; In acetic acid;
Multi-step reaction with 3 steps
1: 96 percent / H2 / PtO2
2: BH3 *Me2 S
3: CF3 CO2 H, anisole
With dimethylsulfide borane complex; hydrogen; methoxybenzene; trifluoroacetic acid; platinum(IV) oxide;
C<sub>37</sub>H<sub>36</sub>N<sub>4</sub>O<sub>5</sub>
188028-33-3

C37 H36 N4 O5

staurosporine
62996-74-1

staurosporine

Conditions
Conditions Yield
With methoxybenzene; trifluoroacetic acid; for 48h;
70%
With methoxybenzene; trifluoroacetic acid; Yield given;

62996-74-1 Upstream products

  • 174291-07-7
    174291-07-7

    ent-7-oxostaurosporine

  • 125035-83-8
    125035-83-8

    7-carbonyl staurosporin

  • 188028-33-3
    188028-33-3

    C37 H36 N4 O5

  • 188028-11-7
    188028-11-7

    C36 H34 N4 O5

62996-74-1 Downstream products

  • 129623-30-9
    129623-30-9

    (5S,6R,7R,9R)-6-methoxy-5-methyl-7-(methylamino)-6,7,8,9,15,16-hexahydro-17-oxa-4b,9a,15-triaza-5,9-methanodibenzo[b,h]cyclonona[jkl]cyclopenta[e]-as-indacen-14(5h)-one

  • 125035-83-8
    125035-83-8

    7-oxoylidenestaurosporine

WANT TO PURCHASE
*Product Name
CasNo
Purity
Quantity
Company name
*Email
*Other Description
*Verification code:
ITEMS MARKED WITH * ARE MANDATORY
Submit now